MRNA

MODERNA INC COMMON STOCK

CUSIP: 60770k107

Market Cap
-
Sector
-
Institutional Owners
0
Institutional Value
-

About

Moderna, Inc. is a biotechnology company that develops and commercializes messenger RNA (mRNA) therapeutics and vaccines using a proprietary platform to design, produce and deliver mRNA-based medicines. The company rose to prominence with a widely used mRNA COVID-19 vaccine and has since scaled manufacturing and global distribution while advancing a broad clinical pipeline across infectious diseases, oncology, rare genetic disorders and other therapeutic areas. Moderna positions itself as a leader in mRNA technology, pursuing partnerships and platform-driven programs to expand beyond vaccines into therapeutics.

Institutional Holders

Loading...